Author： Robak Tadeusz
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.3, 2011-03, pp. : 343-359
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies
Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. :
New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. :
New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
Clinical Cancer Drugs, Vol. 1, Iss. 1, 2013-12 ,pp. :
Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. :
Cambridge Scholars Publishing in association with GSE Research